Article
Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence
2 Mar 2022
Abstract excerpt
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), poses several challenges to clinicians, due to its unpredictable clinical course. The identification of laboratory biomarkers, specific cellular, and molecular mediators of immune response could contribute to the prognosis and management of COVID-19 patients. Of utmost importance is also the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
